Skip To Main Content
Jianying Zhou on Muck Rack

Jianying Zhou

As seen in: Nature, Wiley Online Library, arXiv, Frontiers in Immunology, Frontiers in Nutrition, MDPI, The BMJ, ACM - Association for Computing Machinery, The Lancet, Cell Reports Medicine and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jianying

Contact Jianying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancer

|
By Fei Zhou, Chunxia Su, Wenhua Liang, Wei Tao, Shidong Xu, Dan Liu, Rui Fan, Yaxi Zhang, Yiqian Liu, Lin Wu, Xiangning Fu, Xiaodong Zhang, Ning Shen, Di Ge, Qun Chen, Weimin Mao, Lin Xu, Chun C Chen, Bing Hu, Jian Hu, Jian Zhao, Xiaoqing Liu, Zhidong Liu, Zheng Wang, Zemin Xiao, Wen Lin, Xingya Li, Feng Ye, Yang Liu Verified, Haitao Ma, Yunchao Huang, Jianying Zhou, Zhonglin Wang, Lieming Ding, Weizhi Chen, Jianxing He, Caicun Zhou, Li-Di Xu, Juanjuan Qian, Guoguang Shao, Taiqian Gong
| Nature Verified
Abstract Molecular residual disease (MRD), detected through circulating tumor DNA, has emerged as a promising biomarker for surveillance in patients with early-stage non-small cell lung cancer (NSCLC) following curative-intent resection. Here we report the MRD analysis from the phase 3 EVIDENCE trial, which includes patients with stage II–IIIA resected EGFR-mutated NSCLC who have received either adjuvant icotinib or chemotherapy.
Open in Who Shared Issue with article?

Dietary total antioxidant capacity and risk of breast cancer: a systematic review and dose-response meta-analysis of observational studies

|
By Jianying Zhou, Haiyan Jin, Jing Shan, Ziqing Ye
| Frontiers in Nutrition
Abstract Background: Numerous epidemiological studies have suggested a potential association between the antioxidant capacity of the diet and the risk of breast cancer. Yet, these studies have yielded inconclusive results. We therefore conducted a systematic review and dose-response meta-analysis of observational studies to ascertain the association between dietary total antioxidant capacity (TAC) and breast cancer risk.
Open in Who Shared Issue with article?

Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE‐042 China study

|
By Yi-Long Wu, Li Zhang, Yun Fan, Jianying Zhou
| Wiley Online Library Verified
AE adverse event BICR blinded independent central review CI confidence interval CR complete response DOR duration of response ECOG Eastern Cooperative Oncology Group HR hazard ratio ITT intent to treat NSCLC non~-small-cell lung cancer ORR objective response rate OS overall survival PD progressive disease PD-1 programmed cell death protein 1 PD-L1 programmed cell death ligand 1 PFS progression-free survival PR partial response Q3W every 3 weeks RECIST Response Evaluation Criteria in Solid...
Open in Who Shared Issue with article?
See all 26 licensed articles (27 Total)